Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

The Upside of Stock Buybacks

By Numer de Guia When a company decides to repurchase its stock, it may mean two things. One, it could signify that the outfit has poor business prospects, and the best use of its excess cash is to liquidate some equity. No. 2 is the more positive possibility: It may arise from management's assessment that the stock price is cheap relative to the value of the business -- and that it's worthwhile to buy back some of the shares.

Of course, investors would like to know if the latter reason is behind a buyback decision. That's the idea behind this week's screen. We started with the list of companies ranked 4 STARS (accumulate) or 5 STARS (buy) by Standard & Poor's equity analysts, meaning the stocks are expected to outperform the overall market over the next 6 to 12 months. Thus, based on S&P's fundamental analysis, the stocks are attractively valued.

To further strengthen our case, we then looked for companies with favorable track records: those that have posted 25% growth in operating earnings (on a 12-month trailing basis) over the past three years. Then, we screened for the buyback angle, searching for companies that have reduced their shares outstanding by at least 1% in the past 12 months.

These 16 stocks emerged:

Apollo Group (APOL)

Boeing (BA)

Coventry Health Care (CVH)

ExxonMobil (XOM)

Federated Investors (FII)


IndyMac Bancorp (NDE)

Mentor (MNTR)

Mid-Atlantic Medical (MME)

Nabors Industries (NBR)

Oracle (ORCL)

Scientific-Atlanta (SFA)


Shaw Group (SGR)

Sysco (SYY)

UnitedHealth (UNH) De Guia is a portfolio services analyst for Standard & Poor's

blog comments powered by Disqus